BCAX

AS OF

Nov 13, 04:59 PM (EDT)

Price

$14.24

Change

-$0.67 (-4.49%)

Capitalization

780.1M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

BCAX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Bicara Therapeutics (BCAX) Ownership - Who owns Bicara Therapeutics?

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

BCAX

Capitalization

780M

P/E Ratio

2.65

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

437M

Total Cash/Share

7.97

Total Debt

2.24M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

435M

P/B Ratio

1.94

Cash Flow

N/A

Earnings

-4.66

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

25.80

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-121M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-31.00

Shares Held By Institutions

595M

Shares Outstanding - Current

54.8M

Total Liabilities

18.4M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-14.409

View a ticker or compare two or three

Compare

BCAX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for BCAX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details